Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening Products

Golden Rice An Effective Of Vitamin A
The beta-carotene in so-called "Golden Rice" converts to vitamin A in humans, according to researchers at Baylor College of Medicine and Tufts University in an article that appears in the current issue of the American Journal of Clinical Nutrition.
generic viagra online
Environmental Cues Control Reproductive Timing And Longevity, University Of Minnesota Study Shows
When humans and animals delay reproduction because food or other res are scarce, they may live longer to increase the impact of reproduction, according to a new study by University of Minnesota researchers published in the June 25 issue of PLoS (Public Library of Science) One.
News of the day
NPR Examines Obama's 'Broad' Global Health Strategy; Maternal Health In Afghanistan Discussed At Congressional Briefing
NPR reports on President Obama"s "broad global health strategy," which would increase the amount of funding for family planning, maternal and child health programs to about a "half billion dollars" next year. According to NPR, "the U.S. has committed $230 million [over the next five years] directly to health in Afghanistan, whose government has already built 2,000 health facilities since the collapse of the Taliban regime" (Wilson, 7/15).
Endocrinology

NICE Welcomes Office For Life Sciences New Blueprint To Support Innovative Drugs

NICE today welcomed the Office for Life Sciences new Blueprint to support the life sciences industry, which will also improve patient access to innovative new drugs. Welcoming the Blueprint launch, Andrew Dillon Chief Executive of NICE said: "Securing a successful future for the life sciences industries is important for patients and the UK economy.The Innovation Pass is an opportunity for data to be gathered on potentially important new treatments. NICE has been involved in discussions about the Innovation Pass, and we are looking forward to continuing to play a key role in developing the pass." Mr Dillon continued: "NICE is committed to engaging constructively with the pharmaceutical industry and we are extending the access that companies have to us, as we appraise their products. Later this year, we will begin asking pharmaceutical and other life sciences companies, whose products we are evaluating, to make technical staff available to engage with our advisory Appraisal Committees. They will be able to respond to requests from committee chairs to clarify the data they have submitted and to point out any error of fact in the presentation of their data. We believe that this will give companies more confidence in the way NICE handles the evaluation of their products." NICE


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009